IVERIC bio Balance Sheet Health
Financial Health criteria checks 5/6
IVERIC bio has a total shareholder equity of $477.0M and total debt of $97.0M, which brings its debt-to-equity ratio to 20.3%. Its total assets and total liabilities are $613.4M and $136.4M respectively.
Key information
20.3%
Debt to equity ratio
US$96.99m
Debt
| Interest coverage ratio | n/a |
| Cash | US$599.92m |
| Equity | US$477.05m |
| Total liabilities | US$136.36m |
| Total assets | US$613.41m |
Recent financial health updates
We're Hopeful That IVERIC bio (NASDAQ:ISEE) Will Use Its Cash Wisely
May 20
Here's Why We're Not Too Worried About IVERIC bio's (NASDAQ:ISEE) Cash Burn Situation
Feb 01IVERIC bio (NASDAQ:ISEE) Is In A Good Position To Deliver On Growth Plans
Nov 03Here's Why We're Not Too Worried About IVERIC bio's (NASDAQ:ISEE) Cash Burn Situation
Jul 02Recent updates
Iveric drives Apellis lower as Street reacts to Phase 3 data for GA candidate
Sep 06IVERIC bio Q2 2022 Earnings Preview
Jul 25Iveric bio pay DelSiTech €1.25M upfront to develop new formulations of eye disorder drug Zimura
Jul 05IVERIC bio: A First Take
Jun 23We're Hopeful That IVERIC bio (NASDAQ:ISEE) Will Use Its Cash Wisely
May 20Here's Why We're Not Too Worried About IVERIC bio's (NASDAQ:ISEE) Cash Burn Situation
Feb 01IVERIC bio (NASDAQ:ISEE) Is In A Good Position To Deliver On Growth Plans
Nov 03Estimating The Intrinsic Value Of IVERIC bio, Inc. (NASDAQ:ISEE)
Sep 28Apellis' Loss Is Iveric Bio's Gain In Lucrative Eye Disease Field
Sep 16Here's Why We're Not Too Worried About IVERIC bio's (NASDAQ:ISEE) Cash Burn Situation
Jul 02IVERIC bio discusses GATHER2 enrollment and retention updates and new GATHER1 post-hoc analyses
Jun 18IVERIC bio EPS misses by $0.04
May 05We're Hopeful That IVERIC bio (NASDAQ:ISEE) Will Use Its Cash Wisely
Mar 12We Think IVERIC bio (NASDAQ:ISEE) Can Afford To Drive Business Growth
Nov 27IVERIC bio EPS misses by $0.05
Nov 02Financial Position Analysis
Short Term Liabilities: ISEE's short term assets ($611.5M) exceed its short term liabilities ($39.4M).
Long Term Liabilities: ISEE's short term assets ($611.5M) exceed its long term liabilities ($97.0M).
Debt to Equity History and Analysis
Debt Level: ISEE has more cash than its total debt.
Reducing Debt: ISEE's debt to equity ratio has reduced from 445.2% to 20.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ISEE has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ISEE has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.